Samuels Theodore R. II bought BMY
June 30, 2025 · Form 4 insider transaction
Samuels Theodore R. II bought 1,080 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,080
Price
$0.00
Total value
N/A
InsiderSamuels Theodore R. II
Role—
SecurityDeferred Share Units
Transaction codeA: Grant or award
Transaction dateJune 30, 2025
Filing dateJuly 1, 2025
Shares owned after59,477
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.; Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.